vNARs as Neutralizing Intracellular Therapeutic Agents: Glioblastoma as a Target

vNARs as Neutralizing Intracellular Therapeutic Agents: Glioblastoma as a Target

Glioblastoma is the most prevalent and fatal form of primary brain tumors. New targeted therapeutic strategies for this type of tumor are imperative given the dire prognosis for glioblastoma patients and the poor results of current multimodal therapy. Previously reported drawbacks of antibody-based...

Full description

Bibliographic Details
Main Authors: Alejandro Manzanares-Guzmán, Pavel H. Lugo-Fabres, Tanya A. Camacho-Villegas
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Antibodies
Subjects:
cancer immunotherapy
glioblastoma
molecular targeted therapy
variable new antigen receptors (vNARs)
intrabodies
receptor tyrosine kinase
Online Access:https://www.mdpi.com/2073-4468/13/1/25

Internet

https://www.mdpi.com/2073-4468/13/1/25

Similar Items